- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02203955
Study of Sc-FOS for Pouchitis Prevention
February 20, 2020 updated by: Laura E. Raffals, M.D, Mayo Clinic
Prevention of Pouchitis With Short-Chain Fructooligosaccharide Therapy, A Double-Blind, Placebo-Controlled Trial
The main objective is to compare prebiotic therapy with placebo for the prevention of pouchitis after closure of diverting ileostomy in patients with an ileal pouch anal anastomosis.
This study will also characterize the effects of prebiotics on the fecal microbiota and fecal microbial metabolites and correlate these effects with the primary outcome of development of pouchitis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria:
- Age 18-65 years.
- History of ulcerative colitis
- Ileostomy closure after IPAA
- Ability to give appropriate consent
Exclusion Criteria:
- Crohn's disease.
- Perianal disease (including abscess, fissure, or stricture)
- Pregnancy
- Lactation
- Concurrent treatment for IBD or pouchitis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Short-Chain Fructooligosaccharide
4 chews (8.0 g scFOS) orally per day for 12 months
|
4 chews (8.0 g scFOS) orally for 12 months
|
Placebo Comparator: Maltodextrin
4 chews (maltodextrin) daily for 12 months
|
4 chews (maltodextrin) daily for 12 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Change in Pouchitis Disease Activity Index (PDAI) at One Year
Time Frame: baseline, 1 year
|
In the PDAI, an overall score is calculated from three separate six-point scales comprising of clinical symptoms, endoscopic findings and histological changes.
The PDAI incorporates histological features of acute inflammation, and establishes a cut-off of seven for differentiation between 'pouchitis (≥7 points) and 'no pouchitis' (<7 points).
|
baseline, 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Laura Raffals, MD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2014
Primary Completion (Actual)
December 1, 2017
Study Completion (Actual)
December 1, 2018
Study Registration Dates
First Submitted
July 16, 2014
First Submitted That Met QC Criteria
July 29, 2014
First Posted (Estimate)
July 30, 2014
Study Record Updates
Last Update Posted (Actual)
February 24, 2020
Last Update Submitted That Met QC Criteria
February 20, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-001220
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pouchitis
-
Cedars-Sinai Medical CenterTerminatedPouchitis | Ileal Pouch | Ileal PouchitisUnited States
-
Maia KayalNot yet recruitingPouchitis | Chronic PouchitisUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
Universitaire Ziekenhuizen KU LeuvenJanssen, LPRecruiting
-
Nantes University HospitalRecruiting
-
University of North Carolina, Chapel HillThe Broad Foundation; Crohn's and Colitis Foundation; OpenBiomeTerminated
-
Virginia O. ShafferCompletedUlcerative Colitis Associated PouchitisUnited States
-
Ocera TherapeuticsCompleted
Clinical Trials on Short-Chain Fructooligosaccharide
-
University of MinnesotaCompleted
-
TereosCEN BiotechCompleted
-
SyralCompletedFunctional ConstipationFrance
-
Texas A&M UniversityUnknownChronic Obstructive Pulmonary DiseaseUnited States
-
Universidad Autonoma de ChihuahuaRecruitingPolycystic Ovary SyndromeMexico
-
Universidad Autonoma de ChihuahuaNot yet recruitingIrritable Bowel Syndrome | Constipation-predominant Irritable Bowel Syndrome | Diarrhea- Irritable Bowel Syndrome
-
NYU Langone HealthActive, not recruitingRheumatoid ArthritisUnited States
-
Federal University of São PauloUniversidade Federal do Paraná; Pontifícia Universidade Católica do ParanáCompleted
-
Stanford UniversityNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Recurrent Hematologic MalignancyUnited States
-
KU LeuvenNot yet recruiting